Frontiers in Neurology | Multiple Sclerosis and Neuroimmunology

Original Research

Published on 09 Sep 2021

MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis

in Multiple Sclerosis and Neuroimmunology

Laura Clarke
Simon Arnett
Wajih Bukhari
Elham Khalilidehkordi
Sofia Jimenez Sanchez
Cullen O'Gorman
Jing Sun
Kerri M. Prain
Mark Woodhall
Roger Silvestrini

Frontiers in Neurology

doi 10.3389/fneur.2021.722237

13,811 views
19 citations

Original Research

Published on 09 Sep 2021

Thyroid Function and Anti-thyroid Antibodies in Pediatric Anti-NMDAR Encephalitis

in Multiple Sclerosis and Neuroimmunology

Lianfeng Chen
Wenlin Wu
Yang Tian
Yiru Zeng
Chi Hou
Haixia Zhu
Kelu Zheng
Yani Zhang
Yuanyuan Gao
Bingwei Peng

Frontiers in Neurology

doi 10.3389/fneur.2021.707046

3,669 views
5 citations

Case Report

Published on 09 Sep 2021

Ornidazole-Induced Recurrent Encephalopathy in a Chinese Man: A Rare Case Report and Literature Review

in Multiple Sclerosis and Neuroimmunology

Rong Tang
Jia Liang
Yuanfang Li
Tingting Wu
Yuhao Zhang
Yu Ma
Xu Liu

Frontiers in Neurology

doi 10.3389/fneur.2021.706094

3,243 views
4 citations

Original Research

Published on 08 Sep 2021

Physical, Emotional, Medical, and Socioeconomic Status of Patients With NMOSD: A Cross-Sectional Survey of 123 Cases From a Single Center in North China

in Multiple Sclerosis and Neuroimmunology

Zhen Jia
XiuYu Dong
Shuang Song
Ruoyi Guo
Lu Zhang
Jia Liu
Bin Li

Frontiers in Neurology

doi 10.3389/fneur.2021.737564

2,912 views
3 citations

Original Research

Published on 08 Sep 2021

Increased Autoimmunity in Individuals With Down Syndrome and Moyamoya Disease

in Multiple Sclerosis and Neuroimmunology

Jonathan D. Santoro
Sarah Lee
Anthony C. Wang
Eugenia Ho
Deepti Nagesh
Mellad Khoshnood
Runi Tanna
Ramon A. Durazo-Arvizu
Melanie A. Manning
Brian G. Skotko

Frontiers in Neurology

doi 10.3389/fneur.2021.724969

4,378 views
14 citations

Original Research

Published on 07 Sep 2021

Silybin Alleviates Experimental Autoimmune Encephalomyelitis by Suppressing Dendritic Cell Activation and Th17 Cell Differentiation

in Multiple Sclerosis and Neuroimmunology

Huan-Li Yang
Xiao-Wu Shi

Frontiers in Neurology

doi 10.3389/fneur.2021.659678

3,382 views
10 citations

Case Report

Published on 01 Sep 2021

Case Report: The Use of Rituximab in Antibody-Negative Autoimmune Encephalitis

in Multiple Sclerosis and Neuroimmunology

Soo-Hyun Park
Yong-Chan Kim

Frontiers in Neurology

doi 10.3389/fneur.2021.686009

7,510 views
2 citations

Original Research

Published on 01 Sep 2021

The Dimethyl Fumarate Experience: A Handy Drug With Broad Clinical Utility

in Multiple Sclerosis and Neuroimmunology

Lorena Lorefice
Elisa Casaglia
Marzia Fronza
Jessica Frau
Giuseppe Fenu
Silvy Pilotto
Giancarlo Coghe
Maria A. Barracciu
Eleonora Cocco

Frontiers in Neurology

doi 10.3389/fneur.2021.679355

3,811 views
3 citations

Original Research

Published on 31 Aug 2021

Associations of IRAK1 Gene Polymorphisms and mRNA Expression With NMOSD Risk in the Northern Chinese Han Population

in Multiple Sclerosis and Neuroimmunology

Hongjing Yan
Ruoyi Guo
Weifeng Chen
Xutao Xi
Lianchang Wang
Jianxun Ma
Bin Li

Frontiers in Neurology

doi 10.3389/fneur.2021.661791

2,492 views
3 citations

Original Research

Published on 30 Aug 2021

Evaluation of Thiol Homeostasis in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders

in Multiple Sclerosis and Neuroimmunology

Burak Arslan
Gökçe Ayhan Arslan
Aslı Tuncer
Rana Karabudak
Aylin Sepici Dinçel

Frontiers in Neurology

doi 10.3389/fneur.2021.716195

4,896 views
15 citations

Editorial

Published on 30 Aug 2021

Editorial: Cognition in Multiple Sclerosis

in Multiple Sclerosis and Neuroimmunology

Rosa Cortese
Antonio Carotenuto
Massimiliano Di Filippo
Roberta Lanzillo

Frontiers in Neurology

doi 10.3389/fneur.2021.751687

3,483 views
7 citations

Original Research

Published on 26 Aug 2021

Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing–Remitting Multiple Sclerosis Treated With Dimethylfumarate

in Multiple Sclerosis and Neuroimmunology

Maria C. Buscarinu
Francesca Gargano
Luana Lionetto
Matilde Capi
Emanuele Morena
Arianna Fornasiero
Roberta Reniè
Anna C. Landi
Giulia Pellicciari
Carmela Romano

Frontiers in Neurology

doi 10.3389/fneur.2021.683398

3,510 views
6 citations

Systematic Review

Published on 26 Aug 2021

Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic Review

in Multiple Sclerosis and Neuroimmunology

Nik Krajnc
Gabriel Bsteh
Thomas Berger

Frontiers in Neurology

doi 10.3389/fneur.2021.666868

5,519 views
20 citations

Systematic Review

Published on 26 Aug 2021

Clinical Features of Coexisting Anti-NMDAR and MOG Antibody-Associated Encephalitis: A Systematic Review and Meta-Analysis

in Multiple Sclerosis and Neuroimmunology

Jiayue Ding
Xiangyu Li
Zhiyan Tian

Frontiers in Neurology

doi 10.3389/fneur.2021.711376

7,128 views
31 citations

Original Research

Published on 26 Aug 2021

Analysis of Predictive Risk Factors in Aquaporin-4-IgG Positive Highly Active Neuromyelitis Optica Spectrum Disorders

in Multiple Sclerosis and Neuroimmunology

Yanfei Li
Jinwei Zhang
Yongyan Zhou
Haojie Xie
Ranran Duan
Lijun Jing
Yaobing Yao
Junfang Teng
Yanjie Jia

Frontiers in Neurology

doi 10.3389/fneur.2021.731835

3,386 views
7 citations

Original Research

Published on 23 Aug 2021

Long-Term Efficacy Outcomes of Natalizumab vs. Fingolimod in Patients With Highly Active Relapsing-Remitting Multiple Sclerosis: Real-World Data From a Multiple Sclerosis Reference Center

in Multiple Sclerosis and Neuroimmunology

Marina Boziki
Christos Bakirtzis
Virginia Giantzi
Styliani-Aggeliki Sintila
Stylianos Kallivoulos
Theodora Afrantou
Ioannis Nikolaidis
Panagiotis Ioannidis
Theodoros Karapanayiotides
Ioanna Koutroulou

Frontiers in Neurology

doi 10.3389/fneur.2021.699844

4,329 views
11 citations